Last update 20 Mar 2025

LQ-043H

Overview

Basic Info

Drug Type
Nanobody
Synonyms
+ [1]
Target
TSLP
Action
modulators
Mechanism
TSLP modulators(Thymic stromal lymphopoietin modulators)
Therapeutic Areas
Immune System DiseasesRespiratory Diseases
Active Indication
AsthmaPulmonary Disease, Chronic Obstructive
Inactive Indication-
Originator Organization
Shanghai Novamab Biopharmaceuticals Co., Ltd.Shanghai Novamab Biopharmaceuticals Co., Ltd.
Active Organization
Shanghai Novamab Biopharmaceuticals Co., Ltd.Shanghai Novamab Biopharmaceuticals Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with LQ-043H
ChiCTR2300069500
/ SuspendedPhase 1IIT
Phase Ia clinical study to evaluate the tolerability, safety, pharmacokinetic profiles and immunogenicity of LQ043H single-domain antibody nebulizer after a single dose in healthy Chinese subjects
CTR20230092
/ CompletedPhase 1
评价LQ043H单域抗体雾化液在中国健康受试者中单次给药后的耐受性、安全性、药代动力学和免疫原性的Ⅰa期临床研究
[Translation] A phase Ⅰa clinical study to evaluate the tolerability, safety, pharmacokinetics and immunogenicity of LQ043H single-domain antibody nebulized solution after a single dose in healthy Chinese subjects
100 Clinical Results associated with LQ-043H
Login to view more data
100 Translational Medicine associated with LQ-043H
Login to view more data
100 Patents (Medical) associated with LQ-043H
Login to view more data
100 Deals associated with LQ-043H
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
AsthmaPhase 1
China
Shanghai Novamab Biopharmaceuticals Co., Ltd.Shanghai Novamab Biopharmaceuticals Co., Ltd.
27 Feb 2023
Pulmonary Disease, Chronic ObstructivePreclinical
China
Shanghai Novamab Biopharmaceuticals Co., Ltd.Shanghai Novamab Biopharmaceuticals Co., Ltd.
01 Feb 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free